References
- Dixon BS, Anderson RJ. Nonoliguric acute renal failure. Am J Kidney Dis 1985; 6(2): 71–80
- Zaloga GP, Hughes SS. Oliguria in patients with normal renal function. Anesthesiology 1990; 72(4): 598–602
- French Study Group on Acute Renal Failure. Acute renal failure in intensive care units—causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. Crit Care Med 1996; 24(2): 192–8
- Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol 1981; 15(2): 90–6
- Cohen AJ. Use of diuretics in the intensive care unit. In: Rippe JM, Irwin JM, Alpert JS, et al, eds. Intensive care medicine. 2d ed. Boston: Little, Brown, 1991: 735–7
- Puschett JB. Clinical pharmacologic implications in diuretic selection. Am J Cardiol 1986; 57(2): 6–13A
- Bersten AD, Holt AW. Vasoactive drugs and the importance of renal perfusion pressure. New Horiz 1995; 3(4): 650–61
- Desjars P, Pinaud M, Bugnon D, et al. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17(5): 426–9
- van Meyel JJ, Smits P, Russel FG, et al. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther 1992; 51(4): 440–4
- Martin SJ, Danziger LH. Continuous infusion of loop diuretics in the critically ill: a review of the literature. Crit Care Med 1994; 22(8): 1323–9
- Graziani G, Cantaluppi A, Casati S, et al. Dopamine and frusemide in oliguric acute renal failure. Nephron 1984; 37(1): 39–42
- Rybak LP. Ototoxicity of loop diuretics. Otolaryngol Clin North Am 1993; 26(5): 829–44
- Brater DC. Disposition and response to bumetanide and furosemide. Am J Cardiol 1986; 57(2): 20–5A
- Wollam GL, Tarazi RC, Bravo EL, et al. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 1982; 72(6): 929–38
- Vincent JL. Renal effects of dopamine: can our dream ever come true? (Editorial) Crit Care Med 1994; 22(l): 5–6
- Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994; 22(1): 61–6
- Duke GJ, Briedis JH, Weaver RA. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine? Crit Care Med 1994; 22(12): 1919–25
- Inoue M, Okajima K, Itoh K, et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987; 32(2): 198–203
- Ronco C, Barbacini S, Digito A, et al. Achievements and new directions in continuous renal replacement therapies. New Horiz 1995; 3(4): 708–16
- Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21(3): 328–38